Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Home blood pressure in pregnancy–the upper reference limit

Vestgaard, Mariannea,,b; Carstens Søholm, Juliea,,b; Kjærhus Nørgaard, Sidsea,,b; Ásbjörnsdóttir, Björga,,b; Ringholm, Lenea,,c; Damm, Petera,,b; Mathiesen, Elisabeth R.a,,b,,c

doi: 10.1097/MBP.0000000000000386
Analytical Methods
Buy

Objectives: To investigate whether the upper home blood pressure reference limit in healthy pregnant women correspond to 135/85 mmHg as used when diagnosing white coat hypertension outside pregnancy.

Methods: In this prospective observational study 103 healthy, singleton pregnant women with a mean age of 32 ± 4 (±SD) years and with a median pre-pregnancy body mass index of 21 (interquartile range 20–24) kg/m2 were included. Home blood pressure was measured with the device Microlife® BP 3A Plus twice daily for three days (18 measurements in total) in addition to routine office blood pressure measurements in early (median 12+1 (weeks+days)), mid (20+0) and late pregnancy (35+3). Upper blood pressure reference limits were calculated as mean +2 SD.

Results: Office blood pressure versus home blood pressure were 115 ± 11/72 ± 7 versus 103 ± 7/64 ± 5 mmHg in early pregnancy, 112 ± 11/74 ± 7 versus 102 ± 7/63 ± 5 mmHg in mid pregnancy and 118 ± 11/75 ± 8 versus 107 ± 8/66 ± 6 mmHg in late pregnancy. The mean difference between office blood pressure and home blood pressure was 10 mmHg. In late pregnancy, the upper reference limit was 140/91 mmHg for office blood pressure and 123/78 mmHg for home blood pressure with slightly lower values in early and mid pregnancy, respectively.

Conclusion: In late pregnancy, the upper home blood pressure reference limit in a population of healthy women was 123/78 mmHg. This value questions the generally proposed level of 135/85 mmHg to define white coat hypertension in pregnancy.

aCenter for Pregnant Women with Diabetes, Departments of Endocrinology and Obstetrics, Rigshospitalet, University Hospital of Copenhagen

bThe Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen

cSteno Diabetes Center Copenhagen, Gentofte, Denmark

Received 27 November 2018 Accepted 5 April 2019

Corresponding author: Marianne Vestgaard, MD, Center for Pregnant Women with Diabetes, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark, Tel.: +45 22 41 54 80; e-mail: marianne.jenlev.vestgaard@regionh.dk

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.